Albany, NY -- (SBWIRE) -- 03/09/2016 -- Opioids are naturally occurring opiates and synthetic and semi-synthetic drugs that act on opioid receptors in the brain and can cause dependence due to their euphoric effects. Opioids are majorly categorized into natural and synthetic opioids that are used to treat moderate to severe pain caused due to various physical conditions.

Increasing usage of opioids in non-cancer conditions, unregulated prescription by physicians, lack of regulatory policies to curb the abusive consumption, increasing the prevalence of terminal conditions and favorable reimbursement for palliative care in developed countries are some of the factors promoting the growth of the global opioids market. However, chronic side effects, high prices of opioids in developing countries, over the regulated opioid prescription environment in Asia Pacific and limited availability in Asia Pacific, Africa and some parts of Europe are expected to hinder the growth of the opioids market, globally.

Complete Report with TOC @ http://www.mrrse.com/opioids-market

This report covers the global opioids market performance in terms of revenue contribution. The report includes key trends, drivers, restraints, and opportunities influencing the growth of the global opioids market. Impact analysis of key growth drivers and restraints, based on the weighted average model are included in this report to better equip clients with crystal clear decision-making insights.

The global opioids market is segmented as follows:

Opioid market, by Product Type
Opioid market, by Application
Opioid market, by Region

The global opioids market has been estimated to be valued at US$ 34,888.0 Mn in 2015 and is anticipate to garner US$ 42,158.8 Mn revenue by 2021, registering a CAGR of 3.2% during the forecast period.

Inquiry on this report @ http://www.mrrse.com/enquiry/1609

By product, the global opioid market is segmented into morphine, codeine, fentanyl, meperidine and methadone. The morphine and codeine segments collectively accounted for around 62% of the overall market in 2014.

By application, the global opioids market is segmented into analgesia, cough suppression and diarrhea suppression. The analgesia segment was valued at US$ 22,776.3 Mn in 2014 and is anticipated to reach US$ 28,436.8 Mn by 2021 at a CAGR of 3.3% over the forecast period.

By geography, North America dominated the market with over 65% market share in 2014, followed by Europe. Opioids market in Asia-Pacific is projected to expand at the highest CAGR of 6.7% during the forecast period.

Request a Free Sample Copy of the Report @ http://www.mrrse.com/sample/1609

Key players in the global opioids market are Pfizer Inc., Purdue Pharma, Boehringer Ingelheim, Janssen Pharmaceuticals, Inc., Actavis Plc., Sanofi, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals Inc. and Egalet. These companies are looking for maximum market share with the help of product launch in Abuse Deterrent Formulations (ADF). Also, major players are focusing on Asia Pacific region especially in Australia owing to flexible regulation for opium cultivation.

Key features of this report

Drivers and restraints of the opioids market
Latest product innovations and key developments in the market
Analysis of business strategies of the top players
Opioids market estimates and forecasts

About MRRSE
MRRSE stands for Market Research Reports Search Engine, the largest online catalog of latest market research reports based on industries, companies, and countries. MRRSE sources thousands of industry reports, market statistics, and company profiles from trusted entities and makes them available at a click. Besides well-known private publishers, the reports featured on MRRSE typically come from national statistics agencies, investment agencies, leading media houses, trade unions, governments, and embassies.

Follow us @ https://twitter.com/MRRSEmrrse